{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:45:27Z","timestamp":1790689527392,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00599","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T10:13:45Z","timestamp":1567160025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Non-alcoholic Fatty Liver Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Xi","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo","volume":"34","author":"Williams","year":"2013","journal-title":"Endocr Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science."},{"key":"B4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1503\/cmaj.045232","article-title":"Nonalcoholic fatty liver disease","volume":"172","author":"Adams","year":"2005","journal-title":"CMAJ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/bioinformatics\/btr709","article-title":"Robust rank aggregation for gene list integration and meta-analysis","volume":"28","author":"Kolde","year":"2012","journal-title":"Bioinformatics."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8815","DOI":"10.1002\/jcp.26795","article-title":"Key genes and functional coexpression modules involved in the pathogenesis of systemic lupus erythematosus","volume":"233","author":"Yan","year":"2018","journal-title":"J Cell Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Gene Ontol Consortium Nat Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-9-r60","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkr988","article-title":"KEGG for integration and interpretation of large-scale molecular data sets","volume":"40","author":"Kanehisa","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13059-015-0694-1","article-title":"Comparison of RNA-seq and microarray-based models for clinical endpoint prediction","volume":"16","author":"Zhang","year":"2015","journal-title":"Genome Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/bioinformatics\/bty675","article-title":"Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements","volume":"35","author":"Peters","year":"2019","journal-title":"Bioinformatics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13148-019-0702-5","article-title":"Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome","volume":"11","author":"Sinton","year":"2019","journal-title":"Clin Epigenet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1051\/gse:2008015","article-title":"Characterization of porcine ENO3: genomic and cDNA structure, polymorphism and expression","volume":"40","author":"Wu","year":"2008","journal-title":"Genet Sel Evol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/hep.510250623","article-title":"Hepatic cholesterol metabolism in human obesity","volume":"25","author":"Stahlberg","year":"1997","journal-title":"Hepatology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/oby.2009.49","article-title":"Hepatic gene expression in morbidly obese women: implications for disease susceptibility","volume":"17","author":"Elam","year":"2009","journal-title":"Obesity."},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI0216076","article-title":"Human CYP7A1 deficiency: progress and enigmas","volume":"110","author":"Beigneux","year":"2002","journal-title":"J Clin Invest."},{"key":"B22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0022-2275(20)31482-6","article-title":"Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP","volume":"43","author":"Davis","year":"2002","journal-title":"J Lipid Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7\u03b1-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/FJC.0b013e31823de86b","article-title":"The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate","volume":"59","author":"Shen","year":"2012","journal-title":"J Cardiovasc Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.steroids.2014.11.002","article-title":"Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice","volume":"93","author":"Jones","year":"2015","journal-title":"Steroids."},{"key":"B26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/hep.23721","article-title":"Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"52","author":"Li","year":"2010","journal-title":"Hepatology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/hep.24107","article-title":"Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis","volume":"53","author":"Li","year":"2011","journal-title":"Hepatology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4254\/wjh.v9.i8.443","article-title":"Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease","volume":"9","author":"Wruck","year":"2017","journal-title":"World J Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1471-2407-9-187","article-title":"Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention","volume":"9","author":"Androutsopoulos","year":"2009","journal-title":"BMC Cancer."},{"key":"B30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2018.02.012","article-title":"Modulation of CYP1A1 metabolism: from adverse health effects to chemoprevention and therapeutic options","volume":"187","author":"Mescher","year":"2018","journal-title":"Pharmacol Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.fct.2018.01.029","article-title":"Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice","volume":"113","author":"Uno","year":"2018","journal-title":"Food Chem Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1038\/s41598-018-25743-8","article-title":"Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.5301\/jbm.5000221","article-title":"Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers","volume":"31","author":"Girdhar","year":"2016","journal-title":"Int J Biol Markers."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr15048813","article-title":"Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer","volume":"15","author":"Liu","year":"2016","journal-title":"Genet Mol Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1749-6632.1990.tb17925.x","article-title":"Molecular biology of prolyl 4-hydroxylase","volume":"580","author":"Kivirikko","year":"1990","journal-title":"Ann N Y Acad Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.molmed.2018.10.004","article-title":"Hypoxia-inducible factor prolyl 4-hydroxylases and metabolism","volume":"24","author":"Koivunen","year":"2018","journal-title":"Trends Mol Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s00018-016-2222-1","article-title":"Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease","volume":"73","author":"Lefere","year":"2016","journal-title":"Cell Mol Life Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3109\/10409231003627991","article-title":"Prolyl 4-hydroxylase","volume":"45","author":"Gorres","year":"2010","journal-title":"Crit Rev Biochem Mol Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fendo.2019.00270","article-title":"Hepatic gene expression profiles differentiate steatotic and non-steatotic grafts in liver transplant recipients","volume":"10","author":"Seda","year":"2019","journal-title":"Front Endocrinol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1677\/ERC-07-0226","article-title":"The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists","volume":"15","author":"Costa","year":"2008","journal-title":"Endocr Relat Cancer."},{"key":"B41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPARalpha in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat Rev Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biochi.2016.11.009","article-title":"PPARs and nonalcoholic fatty liver disease","volume":"136","author":"Liss","year":"2017","journal-title":"Biochimie."},{"key":"B44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","article-title":"Roles of PPARs in NAFLD: potential therapeutic targets","volume":"1821","author":"Tailleux","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B45","doi-asserted-by":"publisher","first-page":"16710","DOI":"10.1074\/jbc.273.27.16710","article-title":"Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner","volume":"273","author":"Motojima","year":"1998","journal-title":"J Biol Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J Biol Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3892\/ijmm.16.4.631","article-title":"Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"16","author":"Nakamuta","year":"2005","journal-title":"Int J Mol Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/MPA.0000000000000637","article-title":"Overexpression of p53 improves blood glucose control in an insulin resistant diabetic mouse model","volume":"45","author":"Zhang","year":"2016","journal-title":"Pancreas."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00599\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:16:00Z","timestamp":1664237760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00599\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":50,"alternative-id":["10.3389\/fendo.2019.00599"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00599","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"article-number":"599"}}